| Literature DB >> 22033521 |
Sebastian Treusch1, Shusei Hamamichi, Jessica L Goodman, Kent E S Matlack, Chee Yeun Chung, Valeriya Baru, Joshua M Shulman, Antonio Parrado, Brooke J Bevis, Julie S Valastyan, Haesun Han, Malin Lindhagen-Persson, Eric M Reiman, Denis A Evans, David A Bennett, Anders Olofsson, Philip L DeJager, Rudolph E Tanzi, Kim A Caldwell, Guy A Caldwell, Susan Lindquist.
Abstract
Aβ (beta-amyloid peptide) is an important contributor to Alzheimer's disease (AD). We modeled Aβ toxicity in yeast by directing the peptide to the secretory pathway. A genome-wide screen for toxicity modifiers identified the yeast homolog of phosphatidylinositol binding clathrin assembly protein (PICALM) and other endocytic factors connected to AD whose relationship to Aβ was previously unknown. The factors identified in yeast modified Aβ toxicity in glutamatergic neurons of Caenorhabditis elegans and in primary rat cortical neurons. In yeast, Aβ impaired the endocytic trafficking of a plasma membrane receptor, which was ameliorated by endocytic pathway factors identified in the yeast screen. Thus, links between Aβ, endocytosis, and human AD risk factors can be ascertained with yeast as a model system.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22033521 PMCID: PMC3281757 DOI: 10.1126/science.1213210
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728